Plus, news about OPKO, HealthCare Royalty, Inventiva, Exscientia and GT Apeiron:
Boehringer Ingelheim ups its R&D budget: Back in April, the company said it …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.